Saturday, November 26, 2016 6:14:14 PM
Actually short interest is dropping off a cliff, interesting post though says a lot.
Historical Short Volume Data for BRVO
Date
Close
High
Low
Volume
Short Volume
% of Vol Shorted
Nov 25 0.009 0.009 0.008 1,316,880 5,000 0.38%
Nov 23 0.008 0.008 0.008 1,657,215 10,215 0.62%
Nov 22 0.008 0.009 0.008 1,101,310 28,300 2.57%
Nov 21 0.009 0.009 0.008 861,850 103,000 11.95%
Nov 18 0.009 0.01 0.009 21,700 4,100 18.89%
Nov 17 0.009 0.009 0.009 1,323,038 397,300 30.03%
Nov 16 0.009 0.009 0.008 1,295,129 389,484 30.07%
Nov 15 0.009 0.01 0.008 209,600 16,000 7.63%
Nov 14 0.01 0.011 0.01 1,355,679 766,800 56.56%
Nov 11 0.01 0.012 0.01 529,919 8,000 1.51%
Nov 10 0.012 0.012 0.01 286,698 67,700 23.61%
Nov 09 0.012 0.013 0.01 426,173 219,900 51.60%
Nov 08 0.013 0.013 0.008 227,000 98,100 43.22%
Nov 07 0.01 0.01 0.008 851,779 364,467 42.79%
Nov 04 0.008 0.009 0.008 962,774 647,208 67.22%
Nov 03 0.008 0.008 0.008 485,893 294,038 60.51%
Nov 02 0.008 0.01 0.007 1,467,810 317,806 21.65%
Nov 01 0.01 0.012 0.01 1,318,405 180,000 13.65%
Oct 31 0.011 0.013 0.01 1,156,086 346,832 30.00%
Oct 28 0.012 0.014 0.011 954,314 366,679 38.42%
Oct 27 0.013 0.014
Recent BRVO News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:36:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 08:24:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 09:12:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/22/2023 09:36:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:15:48 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/19/2023 08:31:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 12:27:30 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/28/2023 08:11:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:02:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/07/2023 08:03:17 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM